FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Isocarboxazid Tablets
Status: Currently in Shortage
»Date first posted: 05/15/2018
»Therapeutic Categories: Psychiatry

Validus Pharmaceuticals LLC (Reverified 12/10/2019)

Company Contact Information:
866-982-5438 (1-866-9VALIDUS)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10mg (NDC 30698-032-01) Due to the current critical shortage of Isocarboxazid Tablets in the United States (US) market, Validus Pharmaceuticals LLC is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Isocarboxazid Tablets. Validus has initiated temporary importation of another manufacturer’s Isocarboxazid Tablets into the U.S. market. This product is manufactured and marketed in Denmark by MediLink. MediLink's Marplan is commercially available under a new NDC 72604-032-01.

Dear Healthcare Professional Letter

Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English